|Year : 2016 | Volume
| Issue : 5 | Page : 379-386
Scaffolds in regenerative endodontics: A review
Kinjal M Gathani, Srinidhi Surya Raghavendra
Department of Conservative Dentistry and Endodontics, Sinhgad Dental College and Hospital, Pune, Maharashtra, India
|Date of Web Publication||14-Oct-2016|
Srinidhi Surya Raghavendra
Department of Conservative Dentistry and Endodontics, Sinhgad Dental College and Hospital, Pune, Maharashtra
Source of Support: None, Conflict of Interest: None
Root canal therapy has enabled us to save numerous teeth over the years. The most desired outcome of endodontic treatment would be when diseased or nonvital pulp is replaced with healthy pulp tissue that would revitalize the teeth through regenerative endodontics. 'A search was conducted using the Pubmed and MEDLINE databases for articles with the criteria 'Platelet rich plasma', 'Platelet rich fibrin', 'Stem cells', 'Natural and artificial scaffolds' from 1982-2015'. Tissues are organized as three-dimensional structures, and appropriate scaffolding is necessary to provide a spatially correct position of cell location and regulate differentiation, proliferation, or metabolism of the stem cells. Extracellular matrix molecules control the differentiation of stem cells, and an appropriate scaffold might selectively bind and localize cells, contain growth factors, and undergo biodegradation over time. Different scaffolds facilitate the regeneration of different tissues. To ensure a successful regenerative procedure, it is essential to have a thorough and precise knowledge about the suitable scaffold for the required tissue. This article gives a review on the different scaffolds providing an insight into the new developmental approaches on the horizon.
Keywords: Extracellular matrix, pulp, regeneration, scaffolds
|How to cite this article:|
Gathani KM, Raghavendra SS. Scaffolds in regenerative endodontics: A review. Dent Res J 2016;13:379-86
| Introduction|| |
Regenerative dentistry has been popularized due to advancements in biologic therapies that apply growth and differentiation factors which hasten or induce natural biologic regeneration.Hermann in 1920 described the application of calcium hydroxide for vital pulp therapy which laid the foundation for regeneration of dental tissues.NygaardOstby in 1961 evaluated a revascularization method for re-establishing a pulp-dentin complex in permanent teeth with pulpal necrosis. 
Regenerative endodontics is based on the concept of tissue engineering. Regenerative endodontic procedures (REPs) have been defined as biologically-based procedures designed to replace damaged structures, including dentin and root structures, as well as cells of the pulp-dentin complex with live viable tissues, preferably of the same origin, that restore the normal physiologic functions of the pulp-dentin complex.  'An exhaustive search was conducted using the Pubmed and MEDLINE databases for articles with the criteria 'Platelet rich plasma', 'Platelet rich fibrin', 'Stem cells', 'Natural and artificial scaffolds' from 1982-2015. All articles were selected, with no inclusion or exclusion criteria'.
Pulp revascularization is defined as re-introduction of vascularity in the root canal system.Although blood vessels are indispensable constituents of dental pulp, pulp regeneration is considered incomplete without an odontoblastic layer lining the dentin surface, nociceptive as well as sympathetic and parasympathetic nerve fibers, in addition to interstitial fibroblasts and most importantly, stem/progenitor cells that serve to replenish all pulp cells in the regenerated pulp when they undergo apoptosis and turnover. Thus, a clear distinction between regeneration and revascularization can be made as follows:
- Pulp revascularization = induction of angiogenesis in endodontically-treated root canal
- Pulp regeneration = pulp revascularization + restoration of functional odontoblasts and/or nerve fibers. 
The three key ingredients for regeneration are morphogens, progenitor/stem cells, and the extracellular matrix (ECM) scaffold. 
| Stem cells|| |
Stem cells are undifferentiated embryonic or adult cells that continuously divide. They can divide and create additional stem cells and differentiate along a specified molecular pathway. Embryonic stem cells are totipotent and have the capacity to self-renew. In contrast, stem cells that reside within an adult organ or tissue have more restricted options, with ability to select a differentiation program from only a few possible pathways , [Table 1].
| Growth factors|| |
Growth factors regulate either transplanted cells or endogenous cells in dental pulp-dentin regeneration.They are polypeptides or proteins that bind to specific receptors on the surface of target cells (e.g., bone morphogenetic protein [BMP] receptors) that affect a broad range of cellular activities including migration, proliferation, differentiation, and apoptosis of all dental pulp cells, including stem/progenitor cells.  Bioactive cues that recruit the proper cells are critical in pulp regeneration (transforming growth factors [TGFs] β1, β3 for odontoblast differentiation and stimulation of dentin matrix). These events of repair and regeneration can be coordinated and modulated by growth factors such as platelet-derived growth factor (PDGF), TGF, BMPs, vascular endothelial growth factor (VEGF), fibroblast growth factor, and insulin-like growth factor (IGF). 
| Scaffolds|| |
Scaffolds are three-dimensional (3D) porous solid biomaterials designed which
- Provide a spatially correct position of cell location 
- Promote cell-biomaterial interactions, cell adhesion, and ECM deposition
- Permit sufficient transport of gases, nutrients, and regulatory factors to allow cell survival, proliferation, and differentiation
- Biodegrade at a controllable rate that approximates the rate of tissue regeneration
- Provoke a minimal degree of inflammation or toxicity in vivo. 
Apart from blood cells, most of the normal cells in human tissues are anchorage-dependent residing in a solid matrix called ECM. The best scaffold for an engineered tissue should be the ECM of the target tissue in its native state. 
Ideal requirements of a scaffold
- A high porosity and an adequate pore size are necessary to facilitate cell seeding and diffusion throughout whole structure of both cells and nutrients 
- Should allow effective transport of nutrients, oxygen, and waste 
- Biodegradability is essential, since scaffolds need to be absorbed by the surrounding tissues without the necessity of surgical removal 
- The rate at which degradation occurs has to coincide with the rate of tissue formation 
- Should be biocompatible 
- Should have adequate physical and mechanical strength. 
Classification of scaffolds
Biological or natural scaffolds
See [Table 3].
Platelet rich plasma
Platelet rich plasma (PRP), an autologous first generation platelet concentrate with a rich source of growth factors, has been proposed as a potential addendum/substitute scaffold.  It is easy to prepare, rich in growth factors, and forms a 3D fibrin matrix that helps entrap the growth factors. Platelet concentration in PRP exceeds 1 million/mL, which is 5 times more than that of the normal platelet count.  More number of platelets increases the number of growth factors secreted by them which helps in the proliferation of stem cells to induce healing and regeneration of tissues.  It is a concentrated suspension of different growth factors like PDGF, TGF-b, IGF, VEGF, epidermal growth factor, and epithelial cell growth factor. These are released via degranulation of alpha granules and stimulate bone and soft-tissue healing.  The disadvantages of this procedure include drawing blood in young patients, the need of special equipment and reagents to prepare PRP, and the increased cost of treatment. 
Platelet rich fibrin
Platelet rich fibrin (PRF) is second-generation platelet concentrate named as Choukroun's PRF after its inventor.  The procedure consists of drawing blood which is collected into test tubes without an anticoagulant and is centrifuged instantaneously. A tabletop centrifuge can be used for 10 min at 3000 rpm or for 12 min at 2700 rpm. 
The resultant product consists of three layers:
- Acellular platelet poor plasma at peak level
- PRF clot in intermediate level
- Red fraction of red blood cells at the base level.
The blood coagulation starts instantaneously as it comes in contact with the glass surface due to the lack of anticoagulant. 
Biological properties of platelet rich fibrin
PRF can be considered as an immune concentrate with specific composition and a 3D architecture. It contains multitude of growth factors such as PDGF, TGF β1, and IGF.
Attributes of platelet-rich fibrin
- Ideal biomaterial for pulp-dentin complex regeneration
- Prevents the early encroachment of undesired cells, thereby acts as a viable barrier between desired and undesired cells
- Healing and inter positional biomaterial
- Accelerates wound closure and mucosal healing due to fibrin bandage and growth factor release. 
Biochemical analysis of platelet-rich fibrin
PRF consists of an intimate assembly of cytokines, glycan chains, structural glycoproteins enmeshed within a slowly polymerized fibrin network. These biochemical components have well known synergistic effects on healing processes. Fibrin is the natural guide of angiogenesis. Fibrin constitutes a natural support to immunity. 
Collagen is the major component in extracellular matrices, and provides great tensile strength in tissues. As a scaffold, collagen allows for easy placement of cells and growth factors and allows for replacement with natural tissues after undergoing degradation. ,,
It is biocompatible, biodegradable, has a good tensile strength, simulates natural ECM of dentin, demonstrates high alkaline phosphatase activity, allows soft tissue and hard tissue formation, forms a trap for osteoinductive factors. , Collagen may also be processed into a variety of formats, including porous sponges, gels, and sheets, and can be crosslinked with chemicals to make it stronger or to alter its degradation rate. 
It is mechanically weak and undergoes rapid degradation, undergoes contraction (shrinkage). ,
Chitosan is produced commercially by deacetylation of chitin, which is the structural element in the exoskeleton of crustaceans (such as crabs and shrimp) and cell walls of fungi. The properties of chitosan affect the formation of pores in the scaffolds, thereby influencing the mechanical and biological properties. ,
Chitosan is nontoxic, easily bioabsorbable, shows antibacterial activity, has gel forming ability, increases alkaline phosphatase activity, shows fibroblast and odontoblastic proliferation. , It is a porous scaffold that can be molded into any shape and its hydrophilic property enhances cell attachment and proliferation. ,
It has low strength and inconsistent behavior with seeded cells, difficult to accurately control the size of the hydrogel pores, chemical modifications of chitosan structure could induce toxicity. 
Hyaluronic acid (HA) is one of the glycosaminoglycans in ECM and plays important roles in maintaining morphologic organization by preserving extracellular spaces, and it has been reported to have excellent potential for tissue engineering. This supports osteogenesis and can provide an environment facilitating chondrogenesis when exposed to its initiating factors. ,
It helps in differentiation of dental mesenchymal cells to odontoblasts, contributes to formation of dentin matrix and dental pulp, is biocompatible, biodegradable, bioactive, non immunogenic, and nonthrombogenic, plays a beneficial role in wound healing, can be used as an injectable scaffold and also as HA sponge. ,,
HA is highly water soluble, it degrades rapidly by enzymes such as hyaluronidase  , especially when not in the form of hydrogel and lacks mechanical integrity in an aqueous environment. However, these drawbacks can be overcome by cross linking and modification of HA. 
Demineralized or native dentin matrix
The organic matrix of dentin is known to contain 233 total and 68 common proteins, including a variety of collagenous and non collagenous proteins. Dentin is dominated by a rich ECMand not cells. 
Demineralized dentin matrix (DDM) is nonimmunogenic and mechanically superior.  There is a release of bioactive molecules with DDM that signal associated dentinogenic events.  It shows direct induction of differentiating odontoblast-like cells and indirect matrix synthesis leading to odontoblast differentiation.  It has proved to be biocompatibile, osteoinductive, and osteoconductive. 
Tooth demineralization is time consuming (usually 2-6 days).Drawback of demineralization is that prolonged acid exposure may negatively affect noncollagenous proteins involved in new bone formation. ,
Silk-based biomaterial scaffolds have been extensively used for both soft and hard tissue engineering. 
They are biocompatible and have the ability to support the attachment, proliferation, and differentiation of many different cell types. Silk fibroin (SF) is an enzymatically degradable material, which can be processed into water insoluble implants, injectable hydro gels, and porous sponges.  The ability of SF to support vascularization with good anticoagulant activity and platelet response is encouraging for tissue engineering research and clinical therapy in dentistry.  It has good mechanical strength, elasticity, biodegradability, morphologic flexibility, oxygen and water permeability, and a slow degradation rate that enables gradual replacement of fibroin with newly formed tissue. , SF is less immunogenic and inflammatory, compared with either polylactic-co-glycolic acid (PLGA) or collagens. 
Hard tissue formation consists of osteodentin.  Complete degradation of silk scaffold occurs after 2 years. 
Artificial or synthetic scaffolds
A number of synthetic polymers such as polylactic acid (PLA), poly-l-lactic acid (PLLA), polyglycolic acid (PGA), PLGA, and polyepsiloncaprolactone (PCL) have been used as scaffolds for pulp regeneration. 
The synthetic polymers are nontoxic, biodegradable, and allow precise manipulation of the physicochemical properties such as mechanical stiffness, degradation rate, porosity, and microstructure.  Synthetic polymers are generally degraded by simple hydrolysis, whe natural polymers are mainly degraded enzymatically. 
PLLA is a very strong polymer and has found many applications where structural strength is important. Experiments were carried out by Sakai et al. and Cordeiro et al.showing PLLA scaffolds promoted dental pulp cell differentiation into endothelial cells and odontoblasts. ,
PGA has been used as an artificial scaffold for cell transplantation, and degrades as the cells excrete ECM. 
PLA is an aliphatic polyester, more hydrophobic than PGA. 
PLGA was used as a scaffold to demonstrate that dentin-like tissue formed and pulp-like tissue could be regenerated after 3-4 months.  PLGA in a 50:50 mixture has a degradation time of about 8 weeks. 
PCL is a slowly degrading polymer that have been used toward tissue engineering efforts in bone, either aloneor combined with hydroxyapatite. 
Synthetic polymers can cause a chronic or acute inflammatory host response, and localized pH decrease due to relative acidity of hydrolytically degraded byproducts. 
This group of scaffolds refers to calcium/phosphate materials, bioactive glasses and glass ceramics.  Most common biomaterials in use are calcium phosphate-based (Ca-P) bioceramics.  Ca-P scaffolds include β-TCP or HA and have been widely tested for bone regeneration owing to their properties of resorption, biocompatibility, low immunogenicity, osteoconductivity, bone bonding, and similarity to mineralized tissues. 3D Ca-P porous granules have proved useful in dental tissue engineering by providing favorable 3D substrate conditions for human dental pulp stem cell (hDPSC) growth and odontogenic differentiation. Addition of SiO 2 and ZnO dopants to pure TCP scaffolds increases its mechanical strength as well as cellular proliferation properties. Glass ceramics based on SiO 2 -Na 2 O-CaO-P 2 O 5 are bioactive and offer good crystallization conditions. Release of dissolution products such as Ca-P enhances the osteoblastic activity of the material. 
| Modifications|| |
Scaffolds made of ceramic can be modified to obtain desired permeability, controlled dissolution rate, and specific surface characteristics to enhance cellular activity. Change in pore size and volume affects the mechanical stiffness of the scaffold. Magnesium-based glass ceramics have improved mechanical integrity and high rate of bioactivity. Niobium doped fluorapatite glass ceramic displays excellent attachment, proliferation, and differentiation of hDPSCs on its surface. 
Bioceramics have a time-consuming fabrication, lack of organic phase, nonhomogenous particle size and shape, large grain size, difﬁcult porosity control, difficulty of shaping, brittleness, slow degradation rate, and high density.  When used alone, the bioceramics have low mechanical strength and are brittle. To overcome this disadvantage, they can be combined with polymer scaffolds. 
| Conclusion|| |
REPs have emerged as viable alternatives for the treatment of immature teeth with pulpal necrosis. The clinicians should be aware of the attributes of various scaffolds so that they can select most suitable one for successful results. Combinations of various scaffoldssuch ashydroxyapatite-polymer gels can be used to compensate for their individual shortcomings, which is a significant advantage. Through the use of computer-aided design and 3D printing technologies, scaffolds like polymers can be fabricated into precise geometries with a wide range of bioactive surfaces. Such scaffolds have the potential to provide environments conducive to the growth of specific cell types such as pulpal cells. Future in regenerative endodontics is very promising owing to the discoveries and advancements in scaffold technology.
Financial support and sponsorship
Conflicts of interest
The authors of this manuscript declare that they have no conflicts of interest, real or perceived, and financial or nonfinancial in this article.
| References|| |
Hargreaves KM, Law AS. Regenerative endodontics. In: Hargreaves KM, Cohen S, editors. Cohen′s Pathways of the Pulp. 10 th
ed. St. Louis, Mo.: Mosby Elsevier; 2011. p. 602-19.
Murray PE, Garcia-Godoy F, Hargreaves KM. Regenerative endodontics: A review of current status and a call for action. J Endod 2007;33:377-90.
Mao JJ, Kim SG, Zhou J, Ye L, Cho S, Suzuki T, et al.
Regenerative endodontics: Barriers and strategies for clinical translation. Dent Clin North Am 2012;56:639-49.
Fuchs E, Segre JA. Stem cells: A new lease on life. Cell 2000;100:143-55.
Sedgley CM, Botero TM. Dental stem cells and their sources. Dent Clin North Am 2012;56:549-61.
Kim SG, Zhou J, Solomon C, Zheng Y, Suzuki T, Chen M, et al.
Effects of growth factors on dental stem/progenitor cells. Dent Clin North Am 2012;56:563-75.
Muschler GF, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004;86-A: 1541-58.
Patel H, Bonde M, Srinivasan G. Biodegradable polymer scaffold for tissue engineering. Trends Biomater Artif Organs 2011;25:20-9.
Saber SE. Tissue engineering in endodontics. J Oral Sci 2009;51:495-507.
Marei M. Regenerative Dentistry. San Rafael, Calif.: Morgan & Claypool; 2010.
Arnal-Pastor M. New Scaffolding Materials for Regeneration of Infarcted Myocardium [Doctoral Thesis].: Universitat Politecnica de Valencia, Valencia, Spain, 2013.
Sureshchandra B, Roma M. Regeneration of dental pulp: A myth or hype. Endodontology 2013;13:139-54.
Abou Neel EA, Chrzanowski W, Salih VM, Kim HW, Knowles JC. Tissue engineering in dentistry. J Dent 2014;B: 915-28.
Jadhav GR, Shah N, Logani A. Platelet-rich plasma supplemented revascularization of an immature tooth associated with a periapical lesion in a 40-year-old man. Case Rep Dent 2014;2014:479584.
Jadhav GR, Shah D, Raghavendra SS. Autologus Platelet Rich Fibrin aided Revascularization of an immature, non-vital permanent tooth with apical periodontitis: A case report. J Nat Sci Biol Med 2015;6:224-5.
Vemuri S, Kotha RS, Raghunath RG, Kandregula CR. Root canal revascularization via blood clotting in regenerative endodontics: Essentials and expectations. J Dr NTR Univ Health Sci 2013;2:235-8.
Yang JW, Zhang YF, Sun ZY, Song GT, Chen Z. Dental pulp tissue engineering with bFGF-incorporated silk fibroin scaffolds. J Biomater Appl 2015;30:221-9.
Jadhav GR, Shah N, Logani A. Comparative outcome of revascularization in bilateral, non-vital, immature maxillary anterior teeth supplemented with or without platelet rich plasma: A case series. J Conserv Dent 2013;16:568-72.
Lata P, Chhabra A, Jindal V, Kaur D, Thakur AK. In-vivo
clinical evaluation of regenerative endodontics in immature necrotic permanent teeth with open apex. Dent J Adv Stud 2015;3:26-33.
Jadhav G, Shah N, Logani A. Revascularization with and without platelet-rich plasma in nonvital, immature, anterior teeth: A pilot clinical study. J Endod 2012;38:1581-7.
Kaur P, Puneet VD. Platelet-rich plasma: A novel bioengineering concept. Trends Biomater Artif Organs 2011;25:86-90.
Hotwani K, Sharma K. Platelet rich fibrin - A novel acumen into regenerative endodontic therapy. Restor Dent Endod 2014;39:1-6.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al.
Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e51-5.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al.
Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e37-44.
Shivashankar VY, Johns DA, Vidyanath S, Sam G. Combination of platelet rich fibrin, hydroxyapatite and PRF membrane in the management of large inflammatory periapical lesion. J Conserv Dent 2013;16:261-4.
Narang I, Mittal N, Mishra N. A comparative evaluation of the blood clot, platelet-rich plasma, and platelet-rich fibrin in regeneration of necrotic immature permanent teeth: A clinical study. Contemp Clin Dent 2015;6:63-8.
Yamauchi N, Yamauchi S, Nagaoka H, Duggan D, Zhong S, Lee SM, et al.
Tissue engineering strategies for immature teeth with apical periodontitis. J Endod 2011;37:390-7.
Sumita Y, Honda MJ, Ohara T, Tsuchiya S, Sagara H, Kagami H, et al.
Performance of collagen sponge as a 3-D scaffold for tooth-tissue engineering. Biomaterials 2006;27:3238-48.
Prescott RS, Alsanea R, Fayad MI, Johnson BR, Wenckus CS, Hao J, et al. In vivo
generation of dental pulp-like tissue by using dental pulp stem cells, a collagen scaffold, and dentin matrix protein 1 after subcutaneous transplantation in mice. J Endod 2008;34:421-6.
Nasir NM, Raha MG, Kadri KN, Rampado M, Azlan CA. The study of morphological structure, phase structure and molecular structure of collagen-PEO 600K blends for tissue engineering application. Am J Biochem Biotechnol 2006;2:175-9.
Galler KM. Scaffolds for pulp regeneration and repair. In: Goldberg M, editor. The Dental Pulp: Biology, Pathology, and Regenerative Therapies. Heidelberg, Germany: Springer; 2014. p. 252.
Vaissiere G, Chevallay B, Herbage D, Damour O. Comparative analysis of different collagen-based biomaterials as scaffolds for long-term culture of human fibroblasts. Med Biol Eng Comput 2000;38:205-10.
Hatab TA, Kochaji N, Issa N, Nadra R, Saleh M, Rahmo A, et al
. In vivo
and immunohistochemical study of dentin and pulp tissue regeneration in the root canal. J Chem Pharm Res 2015;7:302-10.
Wikipedia Contributors. Chitosan. Wikipedia. Available from: https://www.en.wikipedia.org/wiki/Chitosan. [Last cited on 2016 Jan 11].
Croisier F, Jérôme C. Chitosan-based biomaterials for tissue engineering. Eur Polym J 2013;49:780-92.
Matsunaga T, Yanagiguchi K, Yamada S, Ohara N, Ikeda T, Hayashi Y. Chitosan monomer promotes tissue regeneration on dental pulp wounds. J Biomed Mater Res A 2006;76:711-20.
Muzzarelli RA. Chitosan composites with inorganic, morphogenetic proteins and stem cells for bone regeneration. Carbohydr Polym 2011;83:1433-45.
Tziafas D, Amar S, Staubli A, Meyer JM, Ruch JV. Effects of glycosaminoglycans on in vitro
mouse dental cells. Arch Oral Biol 1988;33:735-40.
Inuyama Y, Kitamura C, Nishihara T, Morotomi T, Nagayoshi M, Tabata Y, et al.
Effects of hyaluronic acid sponge as a scaffold on odontoblastic cell line and amputated dental pulp. J Biomed Mater Res B Appl Biomater 2010;92:120-8.
Tan L, Wang J, Yin S, Zhu W, Zhou W, Cao Y, et al
. Regeneration of dentin-pulp-like tissue using an injectable tissue engineering technique. RSC Adv 2015;5:59723-37.
Yuan Z, Nie H, Wang S, Lee CH, Li A, Fu SY, et al.
Biomaterial selection for tooth regeneration. Tissue Eng Part B Rev 2011;17:373-88.
Bronzino J. Tissue Engineering and Artificial Organs. Boca Raton: CRC/Taylor and Francis; 2006.
Park ES, Cho HS, Kwon TG, Jang SN, Lee SH, An CH, et al.
Proteomics analysis of human dentin reveals distinct protein expression profiles. J Proteome Res 2009;8:1338-46.
Guo W, He Y, Zhang X, Lu W, Wang C, Yu H, et al.
The use of dentin matrix scaffold and dental follicle cells for dentin regeneration. Biomaterials 2009;30:6708-23.
Liu G, Xu G, Gao Z, Liu Z, Xu J, Wang J, et al.
Demineralized dentin matrix induces odontoblastic differentiation of dental pulp stem cells. Cells Tissues Organs 2016;201:65-76.
Goldberg M, Smith AJ. Cells and extracellular matrices of dentin and pulp: A biological basis for repair and tissue engineering. Crit Rev Oral Biol Med 2004;15:13-27.
Murata M, Sato D, Hino J, Akazawa T, Tazaki J, Ito K, et al.
Acid-insoluble human dentin as carrier material for recombinant human BMP-2. J Biomed Mater Res A 2012;100:571-7.
Movin S, Borring-Møller G. Regeneration of infrabony periodontal defects in humans after implantation of allogenic demineralized dentin. J Clin Periodontol 1982;9:141-7.
Pietrzak WS, Ali SN, Chitturi D, Jacob M, Woodell-May JE. BMP depletion occurs during prolonged acid demineralization of bone: Characterization and implications for graft preparation. Cell Tissue Bank 2011;12:81-8.
Jindal SK. Silk scaffolds for dental tissue engineering. In: Kundu S, editor. Silk Biomaterials for Tissue Engineering and Regenerative Medicine. Amsterdam: Woodhead Publishing; 2014. p. 403-28.
Blitterswijk C, Thomsen P. Tissue Engineering. London: Academic Press; 2008.
Park JY, Yang C, Jung IH, Lim HC, Lee JS, Jung UW, et al.
Regeneration of rabbit calvarial defects using cells-implanted nano-hydroxyapatite coated silk scaffolds. Biomater Res 2015;19:7.
Meinel L, Hofmann S, Karageorgiou V, Kirker-Head C, McCool J, Gronowicz G, et al.
The inflammatory responses to silk films in vitro
and in vivo
. Biomaterials 2005;26:147-55.
Xu WP, Zhang W, Asrican R, Kim HJ, Kaplan DL, Yelick PC. Accurately shaped tooth bud cell-derived mineralized tissue formation on silk scaffolds. Tissue Eng Part A 2008;14:549-57.
Cao Y, Wang B. Biodegradation of silk biomaterials. Int J Mol Sci 2009;10:1514-24.
Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 2003;5:1-16.
Sakai VT, Zhang Z, Dong Z, Neiva KG, Machado MA, Shi S, et al.
SHED differentiate into functional odontoblasts and endothelium. J Dent Res 2010;89:791-6.
Cordeiro MM, Dong Z, Kaneko T, Zhang Z, Miyazawa M, Shi S, et al.
Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth. J Endod 2008;34:962-9.
Gentile P, Chiono V, Carmagnola I, Hatton PV. An overview of poly (lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci 2014;15:3640-59.
Huang GT, Yamaza T, Shea LD, Djouad F, Kuhn NZ, Tuan RS, et al.
Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo
model. Tissue Eng Part A 2010;16:605-15.
Singhal AR, Agrawal CM, Athanasiou KA. Salient degradation features of a 50:50 PLA/PGA scaffold for tissue engineering. Tissue Eng 1996;2:197-207.
Horst OV, Chavez MG, Jheon AH, Desai T, Klein OD. Stem cell and biomaterials research in dental tissue engineering and regeneration. Dent Clin North Am 2012;56:495-520.
Chan G, Mooney DJ. New materials for tissue engineering: Towards greater control over the biological response. Trends Biotechnol 2008;26:382-92.
Sharma S, Srivastava D, Grover S, Sharma V. Biomaterials in tooth tissue engineering: A review. J Clin Diagn Res 2014;8:309-15.
Burdick J, Mauck R. Biomaterials for Tissue Engineering Applications. Vienna: Springer; 2011.
Garg T, Bilandi A, Kapoor B, Kumar S, Joshi R. Scaffold: Tissue engineering and regenerative medicine. Int Res J Pharm 2011;2:37-42.
Khanna-Jain R, Mannerström B, Vuorinen A, Sándor GK, Suuronen R, Miettinen S. Osteogenic differentiation of human dental pulp stem cells on â-tricalcium phosphate/poly (l-lactic acid/caprolactone) three-dimensional scaffolds. J Tissue Eng 2012;3:1-11.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Different Approaches to the Regeneration of Dental Tissues in Regenerative Endodontics
| ||Anna M. Krupinska,Katarzyna Skoskiewicz-Malinowska,Tomasz Staniowski |
| ||Applied Sciences. 2021; 11(4): 1699 |
|[Pubmed] | [DOI]|
||REJENERATIF ENDODONTIK TEDAVIDE BIYOMALZEME SEÇIMI VE DOKU MÜHENDISLIGI UYGULAMALARI
| ||Ozgul CARTI DÖRTERLER,Fatma AYHAN |
| ||European Journal of Science and Technology. 2021; |
|[Pubmed] | [DOI]|
||Oncostatin M enhances osteogenic differentiation of dental pulp stem cells derived from supernumerary teeth
| ||Young Hwan Kim,Jeong Sang Lee,Eun Jin Seo,Jae Kyung Park,Kyungmoo Yea,Jonghyun Shin,Il Ho Jang,Taesung Jeong |
| ||Biochemical and Biophysical Research Communications. 2020; 529(2): 169 |
|[Pubmed] | [DOI]|
||Effect of Surface Modification by Femtosecond Laser on Zirconia Based Ceramics for Screening of Cell-Surface Interaction
| ||A. Daskalova,L. Angelova,A. Carvalho,A. Trifonov,C. Nathala,F. Monteiro,I. Buchvarov |
| ||Applied Surface Science. 2020; : 145914 |
|[Pubmed] | [DOI]|
||Scaffold-based and Scaffold-free Strategies in Dental Pulp Regeneration
| ||Waruna Lakmal Dissanayaka,Chengfei Zhang |
| ||Journal of Endodontics. 2020; 46(9): S81 |
|[Pubmed] | [DOI]|
||Biomimetic Aspects of Restorative Dentistry Biomaterials
| ||Muhammad Sohail Zafar,Faiza Amin,Muhmmad Amber Fareed,Hani Ghabbani,Samiya Riaz,Zohaib Khurshid,Naresh Kumar |
| ||Biomimetics. 2020; 5(3): 34 |
|[Pubmed] | [DOI]|
||Challenges of Engineering Biomimetic Dental and Paradental Tissues
| ||Mohammed E. Grawish,Lamyaa M. Grawish,Hala M. Grawish,Mahmoud M. Grawish,Salwa A. El-Negoly |
| ||Tissue Engineering and Regenerative Medicine. 2020; |
|[Pubmed] | [DOI]|
||Biomineralization of dentin
| ||Libang He,Yu Hao,Li Zhen,Hongling Liu,Meiying Shao,Xin Xu,Kunneng Liang,Yuan Gao,He Yuan,Jianshu Li,Jiyao Li,Lei Cheng,Cor van Loveren |
| ||Journal of Structural Biology. 2019; |
|[Pubmed] | [DOI]|
||Evaluation of the Osteogenic Potential of Different Scaffolds Embedded with Human Stem Cells Originated from Schneiderian Membrane: An In Vitro Study
| ||Rita Bou Assaf,Mohammad Fayyad-Kazan,Fatima Al-Nemer,Rawan Makki,Hussein Fayyad-Kazan,Bassam Badran,Antoine Berbéri |
| ||BioMed Research International. 2019; 2019: 1 |
|[Pubmed] | [DOI]|
||Pulp Regeneration Concepts for Nonvital Teeth: From Tissue Engineering to Clinical Approaches
| ||Valérie Orti,Pierre-Yves Collart-Dutilleul,Sofía Piglionico,Orsolya Pall,Frédéric Cuisinier,Ivan Panayotov |
| ||Tissue Engineering Part B: Reviews. 2018; |
|[Pubmed] | [DOI]|
||Biomimetics in Endodontics: A Review of the Changing Trends in Endodontics
| ||Jalak Patel,Tejal Sheth,Dhwanit Thakore,Dharmesh Dhamat |
| ||Journal of Advanced Oral Research. 2018; 9(1-2): 11 |
|[Pubmed] | [DOI]|
||A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats
| ||Patrícia Rodrigues Orsi,Fernanda Cruz Landim-Alvarenga,Luis Antônio Justulin,Ramon Kaneno,Marjorie de Assis Golim,Daniela Carvalho dos Santos,Camila Fernanda Zorzella Creste,Eunice Oba,Leandro Maia,Benedito Barraviera,Rui Seabra Ferreira |
| ||Stem Cell Research & Therapy. 2017; 8(1) |
|[Pubmed] | [DOI]|
||A prospective clinical study of regenerative endodontic treatment of traumatized immature teeth with necrotic pulps using bi-antibiotic paste
| ||H. Nazzal,K. Kenny,A. Altimimi,J. Kang,M. S. Duggal |
| ||International Endodontic Journal. 2017; |
|[Pubmed] | [DOI]|